D
Dana Sargent
Researcher at Research Triangle Park
Publications - 5
Citations - 1132
Dana Sargent is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Risk assessment & Pyrethroid. The author has an hindex of 5, co-authored 5 publications receiving 1070 citations.
Papers
More filters
Journal ArticleDOI
Mechanisms of pyrethroid neurotoxicity: Implications for cumulative risk assessment
David M. Soderlund,John M. Clark,Larry P. Sheets,Linda S. Mullin,Vincent J Piccirillo,Dana Sargent,James T Stevens,Myra L. Weiner +7 more
TL;DR: The diverse toxic actions and pharmacological effects of pyrethroids suggest that simple additivity models based on combined actions at a single target are not appropriate to assess the risks of cumulative exposure to multiple pyre Throids.
Journal ArticleDOI
Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides
Charles B. Breckenridge,Larry R. Holden,Nicholas C. Sturgess,Myra L. Weiner,Larry P. Sheets,Dana Sargent,David M. Soderlund,Jin-Sung Choi,Steve Symington,J. Marshall Clark,Steve Burr,David E. Ray +11 more
TL;DR: Overall, based upon neurotoxicity data and the effect of pyrethroids on sodium, calcium and chloride ion channels, it is proposed that bioallethrin, cismethrin, tefluthrin, bifenthrin and permethrin belong to one common mechanism group and deltamethrine, lambda-cyhalothrin, cy Fluthrin and cypermethrin belonging to a second.
Journal ArticleDOI
Comparative functional observational battery study of twelve commercial pyrethroid insecticides in male rats following acute oral exposure.
TL;DR: Signs of neurotoxicity in vivo are established that can be used as weight of evidence to determine whether pyrethroid insecticides act through a common mechanism of toxicity in mammals.
Journal ArticleDOI
Approaches for Assessing Risks to Sensitive Populations: Lessons Learned from Evaluating Risks in the Pediatric Population
Ronald N. Hines,Dana Sargent,Herman Autrup,Linda S. Birnbaum,Robert L. Brent,Nancy G. Doerrer,Elaine A. Cohen Hubal,Daland R. Juberg,Christian Laurent,Robert W. Luebke,Klaus Olejniczak,Christopher J. Portier,William Slikker +12 more
TL;DR: This article evaluated key references in the area of pediatric risk to identify a spectrum of methodological approaches and these approaches are considered for their potential to be extrapolated for the identification and assessment of other sensitive populations.
Journal ArticleDOI
Use of the RISK21 roadmap and matrix: human health risk assessment of the use of a pyrethroid in bed netting.
John E. Doe,Deborah R. Lander,Nancy G. Doerrer,Nina E. Heard,Ronald N. Hines,Anna Lowit,Timothy P. Pastoor,Richard D. Phillips,Dana Sargent,James H. Sherman,Jennifer Y. Tanir,Michelle R. Embry +11 more
TL;DR: The evaluation demonstrated the concept of using existing information within the RISK21 matrix to drive the generation of additional data using a value-of-information approach and showed how new methodology such as the use of in vitro studies and assays could be used to answer the specific questions which arise through the useof the matrix.